Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yena Lee

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Current Opinion in Psychiatry|November 18, 2015
Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI)Roger S McIntyre, Yena Lee
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Preventing suicide in the context of the COVID-19 pandemicRoger S McIntyre, Yena Lee
Journal of Clinical Psychopharmacology|March 25, 2017
Reply to Comments by Drs Glue and MenkesRoger S McIntyre, Yena Lee
Psychiatry Research|May 28, 2020
Projected increases in suicide in Canada as a consequence of COVID-19Roger S McIntyre, Yena Lee
Biomedical Engineering Letters|October 14, 2022
Co-culture platform for neuron-astrocyte interaction using optogenetic modulationSeoyoung Hwang, Yena Lee, Sang Beom Jun
The Journal of Clinical Psychiatry|January 10, 2017
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness StudiesJoshua D Rosenblat, Yena Lee, Roger S McIntyre
Journal of Affective Disorders|August 28, 2018
The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysisJoshua D Rosenblat, Yena Lee, Roger S McIntyre
CNS Spectrums|December 20, 2015
Treating to target in major depressive disorder: response to remission to functional recoveryRoger S McIntyre, Yena Lee, Rodrigo B Mansur
CNS Spectrums|January 4, 2017
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disordersRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Expert Opinion on Investigational Drugs|May 3, 2017
The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effectsRoger S McIntyre, Karl Johe, Carola Rong, et al.
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Current Opinion in Psychiatry|November 18, 2015
Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI)Roger S McIntyre, Yena Lee
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Preventing suicide in the context of the COVID-19 pandemicRoger S McIntyre, Yena Lee
Journal of Clinical Psychopharmacology|March 25, 2017
Reply to Comments by Drs Glue and MenkesRoger S McIntyre, Yena Lee
Psychiatry Research|May 28, 2020
Projected increases in suicide in Canada as a consequence of COVID-19Roger S McIntyre, Yena Lee
Biomedical Engineering Letters|October 14, 2022
Co-culture platform for neuron-astrocyte interaction using optogenetic modulationSeoyoung Hwang, Yena Lee, Sang Beom Jun
The Journal of Clinical Psychiatry|January 10, 2017
Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness StudiesJoshua D Rosenblat, Yena Lee, Roger S McIntyre
Journal of Affective Disorders|August 28, 2018
The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysisJoshua D Rosenblat, Yena Lee, Roger S McIntyre
CNS Spectrums|December 20, 2015
Treating to target in major depressive disorder: response to remission to functional recoveryRoger S McIntyre, Yena Lee, Rodrigo B Mansur
CNS Spectrums|January 4, 2017
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disordersRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Expert Opinion on Investigational Drugs|May 3, 2017
The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effectsRoger S McIntyre, Karl Johe, Carola Rong, et al.
Pageof 24